Callitas Health Inc. Stock price Canadian Securities Exchange
Equities
LILY
CA13125C1068
Biotechnology & Medical Research
Sales 2018 | 0.75 1.02 | Sales 2019 | 0.71 0.96 | Capitalization | 3.53M 4.77M |
---|---|---|---|---|---|
Net income 2018 | -5M -6.77M | Net income 2019 | -1M -1.35M | EV / Sales 2018 | 4,852,616 x |
Net Debt 2018 | 319K 432K | Net Debt 2019 | 848K 1.15M | EV / Sales 2019 | 6,168,166 x |
P/E ratio 2018 |
-0.6
x | P/E ratio 2019 |
-1.97
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 72.04% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 18-01-02 | |
Robert Payment
DFI | Director of Finance/CFO | 42 | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Skeith
BRD | Director/Board Member | 69 | 14-11-30 |
William Rodgers
BRD | Director/Board Member | - | - |
Brian Keane
BRD | Director/Board Member | 47 | - |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 45.97B | |
+52.73% | 43.93B | |
+7.15% | 42.34B | |
-8.78% | 28.27B | |
+18.68% | 27.18B | |
-21.92% | 19.44B | |
+14.62% | 13.83B | |
+31.85% | 12.4B | |
+4.47% | 11.45B |